FDA Orange Book · active-ingredient family
Phenmetrazine hydrochloride
Phenmetrazine hydrochloride is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:PRELUDIN · NDA 011752
2
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet, tablet, extended release
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| PRELUDIN×2 | BOEHRINGER INGELHEIM | NDA 011752 | — | Approved Prior to Jan 1, 1982 | |
| PRELUDIN | BOEHRINGER INGELHEIM | NDA 010460 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Phenmetrazine hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

